Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid

被引:29
|
作者
Chiorean, Roxana [1 ,2 ]
Danescu, Sorina [2 ]
Virtic, Oana [1 ]
Mustafa, Mayson B. [1 ]
Baican, Adrian [2 ]
Lischka, Annette [1 ]
Hashimoto, Takashi [3 ]
Kariya, Yoshinobu [4 ]
Koch, Manuel [5 ,6 ]
Sitaru, Cassian [1 ]
机构
[1] Univ Med Ctr Freiburg, Dept Dermatol, Hauptstr 7, D-79104 Freiburg, Germany
[2] Univ Med & Pharm Iuliu Hatieganu, Dept Dermatol, Cluj Napoca, Romania
[3] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan
[4] Fukushima Med Univ, Dept Biochem, Fukushima, Japan
[5] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Cologne, Germany
[6] Univ Cologne, Med Fac, Ctr Biochem, Cologne, Germany
来源
关键词
Autoantibody; Autoimmunity; Autoantigen; ELISA; Extracellular matrix; Immunoassay; Immunobloting; EPIDERMOLYSIS-BULLOSA-ACQUISITA; AUTOIMMUNE SKIN DISEASES; SUBEPIDERMAL BLISTERS; NEONATAL MICE; AUTOANTIBODIES; TARGET; IGG; GLYCOSYLATION; ANTIGEN-180; PROTEIN;
D O I
10.1186/s13023-018-0855-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Mucous membrane pemphigoid is a group of chronic subepithelial autoimmune blistering diseases that mainly affect mucous membranes. Laminin 332-specific autoantibodies are present in approximately 1/3 of the patients, being associated with an increased risk of malignancy. Because of the severe complications, an early recognition of the disease allowing a timely therapy is essential. The gold standard methods for detection of laminin 332-specific autoantibodies, including the immunoprecipitation and immunoblotting are non-quantitative, laborious and restricted to a few specialized laboratories worldwide. In addition, the use of radioimmunoassays, although highly sensitive and specific, are laborious, expensive and tightly regulated. Therefore, there is a stringent need for a quantitative immunoassay for the routine detection of laminin 332-specific autoantibodies more broadly available to diagnostic laboratories. The aim of this study was to compare different antigenic substrates, including native, recombinant laminin 332 and laminin 332-rich keratinocyte extracellular matrix, for development of an ELISA to detect autoantibodies in mucous membrane pemphigoid. Results: Using a relatively large number of sera from MMP patients with well-characterized autoantibody reactivity we show the suitability of ELISA systems using laminin 332 preparations as adjunct diagnostic tools in MMP. While glycosylation of laminin 332 does not appear to influence its recognition by MMP autoantibodies, ELISA systems using both purified, native and recombinant laminin 332 demonstrated a high sensitivity and good correlation with the detection of autoantibodies by immunoblotting. ELISA systems using different laminin 332 preparations represent a feasible and more accessible alternative for a broad range of laboratories. Conclusions: Our findings qualify the use of immunoassays with the laminin 332-rich preparations as an ancillary diagnostic tool in mucous membrane pemphigoid.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases
    Qian, Hua
    Natsuaki, Yohei
    Koga, Hiroshi
    Kawakami, Tamihiro
    Tateishi, Chiharu
    Tsuruta, Daisuke
    Ishii, Norito
    Li, Xiaoguang
    Hashimoto, Takashi
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [42] Keratinocyte footprint assay discriminates anti-laminin-332 mucous membrane pemphigoid from all other forms of pemphigoid
    Giurdanella, F.
    Nijenhuis, M.
    Diercks, G. F. H.
    Jonkman, M. F.
    Pas, H. H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S13 - S13
  • [43] A sensitive and specific ELISA for the detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid (AECP).
    Lazarova, Z
    Lanschuetzer, C
    Yancey, KB
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A35 - A35
  • [44] Anti-epiligrin (laminin 5) cicatricial pemphigoid
    Allbritton, JI
    Nousari, HC
    Anhalt, GJ
    BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (06) : 992 - 996
  • [45] Therapieresistentes Anti-Laminin-332-SchleimhautpemphigoidKomplette Remission unter adjuvanter Immunapherese und RituximabTreatment-refractory anti-laminin 332 mucous membrane pemphigoidRemission following adjuvant immunoadsorption and rituximab
    A. Recke
    I. Shimanovich
    P. Steven
    L. Westermann
    D. Zillikens
    E. Schmidt
    Der Hautarzt, 2011, 62 (11): : 852 - 858
  • [46] Nodular formation in anti-laminin γ1 pemphigoid
    Tomura, Yayoi
    Noto, Mai
    Ishii, Norito
    Hashimoto, Takashi
    Manabe, Motomu
    Osada, Shin-Ichi
    JOURNAL OF DERMATOLOGY, 2020, 47 (03): : E80 - E82
  • [47] Anti-laminin 5 pemphigoid and acquired haemophilia
    Ly, A
    Roth, B
    Causeret, AS
    Jullien, D
    Kanitakis, J
    Faure, M
    Claudy, A
    BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (06) : 1104 - 1105
  • [48] Anti-laminin gamma-1 pemphigoid
    Dainichi, Teruki
    Kurono, Sadamu
    Ohyama, Bungo
    Ishii, Norito
    Sanzen, Noriko
    Hayashi, Maria
    Shimono, Chisei
    Taniguchi, Yukimasa
    Koga, Hiroshi
    Karashima, Tadashi
    Yasumoto, Shinichiro
    Zillikens, Detlef
    Sekiguchi, Kiyotoshi
    Hashimoto, Takashi
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (08) : 2800 - 2805
  • [49] Anti-laminin-332 mucous membrane pemphigoid associated with recurrent metastatic prostate carcinoma: hypothesis for a paraneoplastic phenomenon
    Young, Alexis L.
    Bailey, Elizabeth E.
    Colaco, Shanthi M.
    Engler, Danielle E.
    Grossman, Marc E.
    EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (03) : 401 - 404
  • [50] Anti-laminin γ1 pemphigoid with IgE autoantibodies
    Komatsu-Fujii, T.
    Dainichi, T.
    Kaku, Y.
    Murata, T.
    Nomura, T.
    Kabashima, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (06) : E276 - E278